Medicare Enrolled
Dr. Mary Crow, M.D.
Hematology & Oncology · Kingwood, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Crow from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Crow? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Crow
Dr. Mary Crow is a hematology & oncology in Kingwood, TX, with 20 years in practice. Based on federal Medicare data, Dr. Crow performed 64,335 Medicare services across 1,076 unique beneficiaries.
Between the years covered by Open Payments, Dr. Crow received a total of $24,954 from 99 pharmaceutical and/or device companies across 1181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Crow is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 14% volume in TX$ $24,954 industry payments
Medicare Practice Summary
Medicare Utilization ↗64,335
Medicare services
Top 14% in TX for hematology & oncology
1,076
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,217 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 40,500 | $1 | $3 |
| Anti-nausea injection (fosaprepitant) | 7,650 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 5,940 | $18 | $55 |
| Contrast dye for imaging (iodine-based) | 4,400 | $0 | $0 |
| Dexamethasone injection (steroid) | 1,481 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 960 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 540 | $23 | $82 |
| Office visit, established patient, complex (40-54 min) | 522 | $127 | $481 |
| Office visit, established patient (30-39 min) | 392 | $89 | $347 |
| Flow cytometry, additional marker | 389 | $19 | $61 |
| Drug injection, under skin or into muscle | 325 | $11 | $38 |
| Administration of chemotherapy into vein, 1 hour or less | 237 | $101 | $375 |
| Injection, zoledronic acid, 1 mg | 166 | $7 | $25 |
| Administration of chemotherapy into vein, each additional hour | 146 | $22 | $80 |
| Administration of additional new drug or substance into vein, 1 hour or less | 139 | $51 | $183 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 123 | $46 | $178 |
| Injection, diphenhydramine hcl, up to 50 mg | 90 | $1 | $3 |
| Irrigation of implanted venous access drug delivery device | 59 | $18 | $73 |
| Office visit, established patient (20-29 min) | 47 | $63 | $246 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 39 | $110 | $295 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 38 | $1,169 | $5,567 |
| Ct scan of chest with contrast | 34 | $58 | $437 |
| CT scan of chest, without contrast | 30 | $58 | $328 |
| New patient office visit, complex (60-74 min) | 24 | $165 | $580 |
| CT scan of abdomen and pelvis with contrast | 21 | $155 | $812 |
| Flow cytometry technique for dna or cell analysis, first marker | 16 | $55 | $187 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $17 | $61 |
| New patient office visit (45-59 min) | 13 | $99 | $443 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
64.0% high complexity
33.4% medium
2.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,954
Total received (2018-2024)
Avg $3,565/year across 7 years
Top 18% in TX for hematology & oncology
99
Companies
1,181
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,853 (83.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,016 (12.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,084 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$277
2023$3,994
2022$3,107
2021$3,748
2020$3,234
2019$5,873
2018$4,722
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,775
Novartis Pharmaceuticals Corporation
$1,679
Merck Sharp & Dohme Corporation
$1,441
Amgen Inc.
$1,405
R-Pharm US LLC
$1,306
E.R. Squibb & Sons, L.L.C.
$1,212
PFIZER INC.
$1,044
Astellas Pharma US Inc
$799
AstraZeneca Pharmaceuticals LP
$795
Pharmacyclics LLC, An AbbVie Company
$777
Seagen Inc.
$694
GlaxoSmithKline, LLC.
$622
Eisai Inc.
$584
GENZYME CORPORATION
$535
Lilly USA, LLC
$522
Takeda Pharmaceuticals U.S.A., Inc.
$515
Celgene Corporation
$437
Genentech USA, Inc.
$436
Daiichi Sankyo Inc.
$378
Kite Pharma, Inc.
$344
Boehringer Ingelheim Pharmaceuticals, Inc.
$328
Incyte Corporation
$322
EISAI INC.
$319
Alexion Pharmaceuticals, Inc.
$296
Karyopharm Therapeutics Inc.
$286
Ipsen Biopharmaceuticals, Inc
$242
AVEO Pharmaceuticals, Inc.
$227
AbbVie Inc.
$219
MorphoSys, US Inc.
$211
Merck Sharp & Dohme LLC
$203
Pharmacyclics LLC, an AbbVie Company
$196
Gilead Sciences, Inc.
$189
Teva Pharmaceuticals USA, Inc.
$173
Dendreon Pharmaceuticals LLC
$159
Bayer HealthCare Pharmaceuticals Inc.
$158
Puma Biotechnology, Inc.
$150
BeiGene USA, Inc.
$145
Stemline Therapeutics Inc.
$135
Exelixis Inc.
$127
Regeneron Healthcare Solutions, Inc.
$110
TESARO, Inc.
$101
Janssen Pharmaceuticals, Inc
$100
ABBVIE INC.
$93
Foundation Medicine, Inc.
$92
Rigel Pharmaceuticals, Inc.
$90
TAIHO ONCOLOGY, INC.
$88
Agios Pharmaceuticals, Inc.
$87
SOBI, INC
$87
Taiho Oncology, Inc.
$84
CTI BioPharma Corp.
$81
SERVIER PHARMACEUTICALS LLC
$69
JAZZ PHARMACEUTICALS INC.
$69
Myovant Sciences Inc.
$68
Dova Pharmaceuticals
$63
Kyowa Kirin, Inc.
$61
TOLMAR Pharmaceuticals, Inc.
$60
Coherus Biosciences Inc.
$56
Genmab U.S., Inc.
$54
Spectrum Pharmaceuticals Inc.
$51
Adaptive Biotechnologies Corporation
$44
Acrotech Biopharma LLC
$44
ARRAY BIOPHARMA INC
$43
Secura Bio, Inc.
$43
G1 Therapeutics, Inc.
$42
Deciphera Pharmaceuticals Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$39
Pharming Healthcare, Inc.
$39
Acceleron Pharma, Inc.
$37
Lexicon Pharmaceuticals, Inc.
$36
AMAG Pharmaceuticals, Inc.
$33
Mirati Therapeutics, Inc.
$32
Seattle Genetics, Inc.
$30
TerSera Therapeutics LLC
$29
Sumitomo Pharma America, Inc.
$27
Mylan Institutional Inc.
$27
Emmaus Medical, Inc.
$24
NOVARTIS PHARMACEUTICALS CORPORATION
$24
Blueprint Medicines Corporation
$23
MACROGENICS, INC.
$22
Abbott Laboratories
$21
MEDIVATION FIELD SOLUTIONS LLC
$21
SpringWorks Therapeutics, Inc.
$20
Sandoz Inc.
$20
EUSA Pharma (US) LLC
$19
Sirtex Medical Inc
$19
Clovis Oncology, Inc.
$17
Helsinn Therapeutics (U.S.), Inc.
$17
Nestle HealthCare Nutrition Inc.
$17
Jazz Pharmaceuticals Inc.
$16
Boston Scientific Corporation
$16
ADC Therapeutics America, Inc.
$16
Advanced Accelerator Applications
$15
Global Blood Therapeutics, Inc.
$15
Pharmacosmos Therapeutics Inc.
$15
Tactile Systems Technology Inc
$15
Array BioPharma Inc.
$14
Allergan Inc.
$14
Blue Earth Diagnostics Limited
$12
Heron Therapeutics, Inc.
$6
Top 3 companies account for 23.6% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · BYSTOLIC · Balversa · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CARDIOMEMS · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · DALVANCE · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · Endari · Enhertu · Erivedge · Erleada · FARYDAK · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · Farydak · Folotyn · Fulphila · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUX-Dx Insertable Cardiac Monitor · LYNPARZA · Lenvima · Lonsurf · Lutathera · MARGENZA · MEKINIST · MK-7339 · MONJUVI · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · ROLVEDON · RUCONEST · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIMPONI ARIA · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TEFLARO · TIBSOVO · TIVDAK · TRUSELTIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · Trodelvy · Truxima · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VYNDAQEL · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZARXIO · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $39 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
41
Per 100K population
0.9
County median income
$73,104
Nearest hospital
KINGWOOD PINES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Crow is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), and high industry engagement (low-engagement, top 18%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Crow experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Crow performed 40,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Crow receive payments from pharmaceutical companies?
Yes. Dr. Crow received a total of $24,954 from 99 companies across 1,181 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Crow's costs compare to other hematology & oncologys in Kingwood?
Dr. Crow's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Crow) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Kingwood
Browse hematology & oncologys in Kingwood ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology